Which stocks in any sector do Indian mutual fund managers prefer most? — August 2026 data
| # | Stock Name | No. of MFs Holding | Avg Weight (%) | Total MF Value (Cr) |
|---|---|---|---|---|
| 61 | JB Chemicals & Pharmaceuticals Limited | 9 funds | 11.74% | ₹160 Cr |
| 62 | Gujarat Themis Biosyn Limited | 8 funds | 1.31% | ₹119 Cr |
| 63 | EQ - WINDLAS BIOTEC LTD | 6 funds | 0.46% | ₹137 Cr |
| 64 | Novartis India Limited | 6 funds | 0.45% | ₹24 Cr |
| 65 | Hikal Limited | 6 funds | 0.47% | ₹220 Cr |
| 66 | Unichem Laboratories Ltd. | 5 funds | 0.49% | ₹339 Cr |
| 67 | Amrutanjan Health Care Ltd. | 5 funds | 0.99% | ₹44 Cr |
| 68 | Sai Parenterals Limited | 4 funds | 0.27% | ₹7 Cr |
| 69 | IOL Chemicals and Pharmaceuticals Limited | 4 funds | 0.79% | ₹15 Cr |
| 70 | Solara Active Pharma Sciences Limited | 4 funds | 0.07% | ₹27 Cr |
| 71 | Dishman Carbogen Amcis Limited | 4 funds | 0.20% | ₹40 Cr |
| 72 | Zota Health Care Limited | 3 funds | 0.53% | ₹20 Cr |
| 73 | RPG Life Sciences Limited | 3 funds | 0.05% | ₹5 L |
| 74 | Bajaj Healthcare Limited | 3 funds | 0.20% | ₹19 Cr |
| 75 | Morepen Laboratories Limited | 3 funds | 0.16% | ₹16 L |
| 76 | Syncom Formulations India Limited | 2 funds | 0.06% | ₹4 L |
| 77 | Sigachi Industries Limited | 2 funds | 0.05% | ₹3 L |
| 78 | Shree Ganesh Remedies Limited | 2 funds | 0.01% | ₹1 L |
| 79 | Lincoln Pharmaceuticals Limited | 2 funds | 0.04% | ₹2 L |
| 80 | SMS Pharmaceuticals Limited | 2 funds | 0.07% | ₹4 L |
The table above ranks the top 20 stocks in the Pharmaceuticals & Biotechnology sector by the number of Indian mutual fund schemes holding them as of August 2026. When a large number of fund managers independently choose the same stock, it is a powerful signal of institutional conviction — these are the stocks that professional money managers believe in most.
A stock held by 200+ mutual funds means that hundreds of fund managers — each doing their own independent research — have concluded that this stock deserves a place in their portfolio. This collective wisdom is one of the most reliable indicators of a stock's quality within its sector. The average weight shows how much of their portfolio each fund typically allocates to the stock, and the total MF value shows the combined rupee investment across all funds holding it.
All data is sourced from monthly portfolio disclosures that every AMFI-registered mutual fund is required to publish. RightAdvise compiles and analyses this data across 1,100+ active fund schemes to give you a clear, unbiased view of where professional fund managers are investing in the Pharmaceuticals & Biotechnology sector. Click any stock name in the table to see which specific funds hold it and in what proportion.